Tradestie Institutional Equity Comparison Engine

HHS vs HNI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HNI Overall Edge

HNI Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HNI Corporation (HNI) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, HHS trades at 14.3x Forward P/E with -3.2% operating margin (-1.7% YoY revenue) versus HNI at 10.3x Forward P/E and 6.6% operating margin (+132.9% YoY). In options structure, HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HNI sits in UNCLASSIFIED (45th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HNI
HHS 14.3x vs HNI 10.3x Fwd P/E
Growth & Margin Winner HNI
Op Margin -3.2% vs 6.6% ยท YoY -1.7% vs +132.9%
Momentum & Technical Winner HNI
1Y +8.8% vs +24.2% ยท 52W Pos 69% vs 82%
Options & Structure Winner HNI
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (45th %ile IV)
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
1M Return -10.49%
1Y Return +8.78%
Forward P/E 14.3x
Unified AI Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
HNI NYSE
HNI Corporation
Office Furniture (No Wood)
$48.48
+0.34% 1D
Market Cap $3.5B
1M Return +3.45%
1Y Return +24.17%
Forward P/E 10.3x
Unified AI Score
49.8 / 100 HOLD
Tech 45.0 Fund 43.0 Flow 50.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HHS +8.78% HNI +24.17% Spread: +10.57 pp (HHS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HHS TTM Op. Margin: -3.2% HNI TTM Op. Margin: 6.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs HNI. Trailing 12-month operating profitability (HHS -3.2% vs HNI 6.6%) and valuation multiples (HHS 14.3x vs HNI 10.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HHS (2) vs HNI (8)
Institutional Metric HHS HNI Criterion Row Winner
Market Capitalization Scale $30.0M $3.5B Larger Scale HNI
Trailing P/E Ratio Valuation 14.3x N/M Lower Multiple HHS
Forward P/E Ratio Valuation 14.3x 10.3x Lower Multiple HNI
Revenue Growth (YoY) Growth -1.7% +132.9% Higher Growth HNI
Operating Margin (TTM) Profitability -3.2% 6.6% Higher Margin HNI
Net Profit Margin Profitability -3.7% 1.0% Higher Margin HNI
Return on Equity (ROE) Capital Efficiency -30.4% 3.9% Higher ROE HNI
52-Week Range Position Momentum 69% ($2โ€“$5) 82% ($29โ€“$53) Stronger Trend HNI
Beta / 30D Volatility Risk Regime 0.49ฮฒ ยท 46% Vol 0.86ฮฒ ยท 38% Vol Lower Realized Risk HNI
Unified Institutional Score Composite Signal 61.8 / 100 (BUY) 49.8 / 100 (HOLD) Higher Composite HHS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HHS vs HNI Buy Guide
HHS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HHS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HNI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 45th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live HNI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HHS nor HNI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.